The Patent Finder

Oculis Operations Sàrl

8 patents currently held · Updated Nov 22, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Previously recorded as Oculis Operations GmbH (to 2024)

0
Ending by 2030
Nov 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 22, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,233,133Preparation of Solid Cyclodextrin Complexes for Ophthalmic Active Pharmaceutical Ingredient Delivery
In force
 · Medium confidence
In forceMedium confidence
US 12,521,448Preparation of Solid Cyclodextrin Complexes for Ophthalmic Active Pharmaceutical Ingredient Delivery
In force
 · Medium confidence
In forceMedium confidence
US 12,383,565Treatment of Diabetic Retinopathy with Ophthalmic Compositions
In force
 · Low confidence
In forceLow confidence
US 12,397,000Stabilized Ophthalmic Dexamethasone Compositions
In force
 · High confidence
In forceHigh confidence
US 12,397,001Treatment of Ocular Inflammation with Ophthalmic Compositions
In force
 · High confidence
In forceHigh confidence
US 12,397,002PH Stabilized Ophthalmic Dexamethasone Compositions
In force
 · High confidence
In forceHigh confidence
US 12,403,147Treatment of Ocular Inflammation Following Ocular Surgery
In force
 · High confidence
In forceHigh confidence
US 12,403,148PH Stabilized Ophthalmic Compositions
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 4 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned · 2 no status recorded

Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/313,674PH Stabilized Ophthalmic CompositionsAug 28, 2025Pending
19/244,594Synthesis of Small Molecule Agonists of NeuroptrophinJun 20, 2025Pending
18/917,928Method of Treating Diabetic Macular EdemaOct 16, 2024Pending
18/792,377Aug 1, 2024No status recorded
18/383,999Ocular Inflammation Treatment with Stabilized DexamethasoneOct 26, 2023Abandoned
18/383,987Oct 26, 2023No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited